Lilly Mergers and Acquisitions Summary

Life ScienceCompany

Lilly has acquired 27 companies, including 9 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 9 assets.

Lilly’s largest acquisition to date was in 2019, when it acquired Loxo Oncology for $8.0B. It’s largest disclosed sale occurred in 1998, when it sold PCS Health Systems to Rite Aid for $1.5B. Lilly has acquired in 10 different US states, and 4 countries. The Company’s most targeted sectors include life science (75%) and healthcare services (12%).

Join Mergr and gain access to Lilly’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity36
    • M&A Buy Activity27
    • M&A Sell Activity9
  • Total Sectors Invested 4
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 17
  • M&A Advisors 13

Lilly

Eli Lilly and Co.

Lilly Corporate Center,
Indianapolis, Indiana 46285
United States,
(317) 276-2000
www.lilly.com

Lilly and Company discovers, develops, manufactures, and markets products in two business segments—human pharmaceutical products and animal health products. The mission of its human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Most of the products Eli Lilly sells were discovered or developed by its own scientists, and the Company's success depends to a great extent on its ability to continue to discover, develop, and bring to market innovative new medicines. Eli Lilly's animal health business, operating through its Elanco division, develops, manufactures, and markets products for both food animals and companion animals. Eli Lilly manufactures and distributes its products through facilities in the US, Puerto Rico, and 11 other countries. Eli Lilly was originally founded in 1876 and is based in Indianapolis, Indiana.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.8/yr) # 18 1 3 1 4 - 27
vol $19.6B $960M $1.7B $8.0B $2.1B $32.4B
Sell (0.2/yr) # 8 - - 1 - - 9
vol $2.0B $375M $2.3B
  36

Most Recent M&A

Company Date Value Type
Prevail Therapeutics, Inc. 2020-12-15 880M USD Add-on Acquisition
New York, New York · www.prevailtherapeutics.com
Disarm Therapeutics 2020-10-15 135M USD Add-on Acquisition
Cambridge, Massachusetts · www.disarmtx.com
Dermira, Inc. 2020-01-10 1.1B USD Add-on Acquisition
Menlo Park, California · www.dermira.com
Protomer Technologies, Inc. 2020-01-01 - Stake Purchase
Pasadena, California · www.protomer.com
Eli Lilly and Co. - Antibiotics Brands & Manufacturing Facility 2019-04-22 375M USD Divestiture
Indianapolis, Indiana
Loxo Oncology, Inc. 2019-01-07 8.0B USD Add-on Acquisition
Stamford, Connecticut · www.loxooncology.com
Hydra Biosciences, Inc. - Pre-Clinical Pain Program 2018-12-14 - Divestiture
Cambridge, Massachusetts
AurKa Pharma, Inc. 2018-05-14 110M USD Add-on Acquisition
Montreal, Quebec
ARMO BioSciences, Inc. 2018-05-10 1.6B USD Add-on Acquisition
Redwood City, California · www.armobio.com
CoLucid Pharmaceuticals, Inc. 2017-01-18 960M USD Add-on Acquisition
Cambridge, Massachusetts · www.colucid.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Elanco Animal Health, Inc.    - Elanco Animal Health, Inc. - StandGuard 2020-07-16 2
Greenfield, Indiana · www.elanco.com Greenfield, Indiana
Elanco Animal Health, Inc.    - Elanco Animal Health, Inc. - Capstar 2020-01-13 1
Greenfield, Indiana · www.elanco.com Greenfield, Indiana
Elanco Animal Health, Inc.    - Bayer AG - Animal Health Business 2019-08-20 11
Greenfield, Indiana · www.elanco.com Leverkusen, Germany
Arteaus Therapeutics LLC    - Arteaus Therapeutics LLC - Emgality Royalty 2019-04-01 1
Cambridge, Massachusetts Cambridge, Massachusetts
Elanco Animal Health, Inc.    - Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines 2016-10-05 10
Greenfield, Indiana · www.elanco.com St. Joseph, Montana
Elanco Animal Health, Inc.    - Janssen Pharmaceuticals - Animal Health Business 2011-03-14 9
Greenfield, Indiana · www.elanco.com Beerse, Belgium
Elanco Animal Health, Inc.    - Posilac(R) 2008-08-20 8
Greenfield, Indiana · www.elanco.com , United States
Elanco Animal Health, Inc.    - Monsanto Co - Posila Dairy Business 2008-08-20 7
Greenfield, Indiana · www.elanco.com , United States

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 20 (74%) 28.0B (86%) 3 (33%) 410M (18%)
Medical Products 3 (11%) - 2 (22%) 375M (16%)
Healthcare Services 3 (11%) 4.4B (14%) 1 (11%) 1.5B (64%)
Technology Hardware 1 (4%) - 1 (11%) 4M (< 1%)
Distribution - - 1 (11%) -
Test/Measurement Equipment - - 1 (11%) 50M (2%)
Total 27 $32.4B 9 $2.3B

By Geo

State/Country Buy Value Sell Value
United States 23 26.8B 9 2.3B
  California 9 3.1B 1 4M
  Massachusetts 5 1.6B - -
  Indiana - - 5 835M
  Washington 2 2.1B 1 -
  Arizona 1 4.4B 1 1.5B
  Connecticut 1 8.0B - -
  Pennsylvania 1 300M - -
  New York 1 880M - -
  New Jersey 1 6.5B - -
  Kansas 1 - - -
  Tennessee - - 1 -
Canada 2 110M - -
  Quebec 2 110M - -
Germany 1 25M - -
Switzerland 1 5.4B - -
Domestic 23 (85%) 26.8B (83%) 9 (100%) 2.3B (100%)
Cross-border 4 (15%) 5.5B (17%) - -
Total 27 $32.4B 9 $2.3B

Top M&A Advisors

Financial Deals
Deutsche Bank Corporate & Investment Banking
2
UBS Investment Bank
1
Lazard Ltd.
1
Legal Deals
Weil Gotshal & Manges LLP
5
Latham & Watkins
1
Dewey & LeBoeuf LLP
1

Deal Values

buy # Total
> $1B 7 $29.1B
$100M to $1B 8 $3.2B
< $100M 2 $89M
TOTAL $32.4B
Largest Loxo Oncology, Inc.
$8.0B (2019-01-07)
sell # Total
> $1B 1 $1.5B
$100M to $1B 2 $785M
< $100M 2 $54M
TOTAL $2.3B
Largest PCS Health Systems Inc.
$1.5B (1998-11-18)

M&A Connections

Deals
Acquired from
Investor(s)
7%
2 (7%)
Strategic(s)
26%
7 (26%)
Divested to
Investor(s)
11%
1 (11%)
Strategic(s)
78%
7 (78%)

 Subscribe to unlock this and 169,851
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 159K M&A Transactions
  • 166K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 57K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.